These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 33994251)

  • 1. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling.
    Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P
    Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice.
    Pan J; Zhang C; Shi M; Guo F; Liu J; Li L; Ren Q; Tao S; Tang M; Ye H; Ma L; Fu P
    J Ethnopharmacol; 2021 Jan; 264():113278. PubMed ID: 32841699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
    Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
    Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice.
    Wang M; Zhao J; Zhang N; Chen J
    Biomed Pharmacother; 2016 Oct; 83():975-988. PubMed ID: 27522260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
    Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J
    Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy.
    Shi M; Guo F; Liao D; Huang R; Feng Y; Zeng X; Ma L; Fu P
    Eur J Pharmacol; 2020 Nov; 887():173570. PubMed ID: 32949603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterostilbene, a bioactive component of blueberries, alleviates renal fibrosis in a severe mouse model of hyperuricemic nephropathy.
    Pan J; Shi M; Li L; Liu J; Guo F; Feng Y; Ma L; Fu P
    Biomed Pharmacother; 2019 Jan; 109():1802-1808. PubMed ID: 30551434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.
    Liu N; Xu L; Shi Y; Fang L; Gu H; Wang H; Ding X; Zhuang S
    Oncotarget; 2017 May; 8(20):33807-33826. PubMed ID: 28442634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eurycoma longifolia alkaloid components ameliorate hyperuricemic nephropathy via regulating serum uric acid level and relieving inflammatory reaction.
    Wang D; Liu L; Li K; Cao H; Liu M; Chen Q; Wu Y; Zhang Y; Wang T
    J Nat Med; 2023 Sep; 77(4):867-879. PubMed ID: 37433989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways.
    Ren Q; Wang B; Guo F; Huang R; Tan Z; Ma L; Fu P
    Front Pharmacol; 2021; 12():792139. PubMed ID: 35153751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice.
    Lu M; Yin J; Xu T; Dai X; Liu T; Zhang Y; Wang S; Liu Y; Shi H; Zhang Y; Mo F; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117262. PubMed ID: 37788785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypouricemic and Nephroprotective Effects of Emodinol in Oxonate-Induced Hyperuricemic Mice are Mediated by Organic Ion Transporters and OIT3.
    Hui W; Yongliang Y; Yongde C; Guo L; Li L; Zhonglin Y; Hui J; Qinghua H
    Planta Med; 2016 Mar; 82(4):289-297. PubMed ID: 26584455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
    Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
    Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
    Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
    Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats.
    Huijuan W; Xiaoxu C; Rui S; Xinghui L; Beibei T; Jianchun M
    Biomed Pharmacother; 2017 Jul; 91():358-365. PubMed ID: 28463799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-
    Liu P; Wang C; Wang Y; Zhang H; Liu B; Qiu X
    Biomed Res Int; 2021; 2021():2793823. PubMed ID: 34938805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice.
    Zhang Y; Wang S; Dai X; Liu T; Liu Y; Shi H; Yin J; Xu T; Zhang Y; Zhao D; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D
    J Ethnopharmacol; 2023 Aug; 312():116530. PubMed ID: 37098372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice.
    Wang R; Ma CH; Zhou F; Kong LD
    Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model.
    Wang X; Deng J; Xiong C; Chen H; Zhou Q; Xia Y; Shao X; Zou H
    Drug Des Devel Ther; 2020; 14():2221-2233. PubMed ID: 32606592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice.
    Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD
    J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.